Журнал "Современная оптометрия" №10-2021 | Page 42

× òî ìû êîíòðîëèðóåì : ïðîãðåññèðîâàíèå ìèîïèè èëè ðîñò ãëàçà ?

Ñïèñîê ëèòåðàòóðû
1 . Saxena R , Dhiman R , Gupta V [ et al .]. Atropine for Treatment of Childhood Myopia in India ( I-Atom ): Multicentric Randomized Trial . Ophthalmology 2021 .
2 . Wei S , Li SM , An W [ et al .]. Safety and Efficacy of Low- Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children : A Randomized Clinical Trial . JAMA ophthalmology 2020 .
3 . Yam JC , Jiang Y , Tang SM [ et al .]. Low-Concentration Atropine for Myopia Progression ( Lamp ) Study : A Randomized , Double-Blinded , Placebo-Controlled Trial of 0,05 %, 0,025 %, and 0,01 % Atropine Eye Drops in Myopia Control . Ophthalmology 2019 ; 126 : 113 – 124 .
4 . Hieda O , Hiraoka T , Fujikado T [ et al .]. Efficacy and Safety of 0,01 % Atropine for Prevention of Childhood Myopia in a 2-Year Randomized Placebo-Controlled Study . Japanese journal of ophthalmology 2021 .
5 . Aller TA , Liu M , Wildsoet CF . Myopia Control with Bifocal Contact Lenses : A Randomized Clinical Trial . Optom Vis Sci 2016 ; 93 : 344 – 352 .
6 . Anstice NS , Phillips JR . Effect of Dual-Focus Soft Contact Lens Wear on Axial Myopia Progression in Children . Ophthalmology 2011 ; 118 : 1152 – 1161 .
7 . Chamberlain P , Peixoto-de-Matos SC , Logan NS [ et al .]. A 3-Year Randomized Clinical Trial of Misight Lenses for Myopia Control . Optom Vis Sci 2019 ; 96 : 556 – 567 .
8 . Walline JJ , Walker MK , Mutti DO [ et al .]. Effect of High Add Power , Medium Add Power , or Single-Vision Contact Lenses on Myopia Progression in Children : The Blink Randomized Clinical Trial . JAMA 2020 ; 324 : 571 – 580 .
9 . Lam CS , Tang WC , Tse DY [ et al .]. Defocus Incorporated Soft Contact ( Disc ) Lens Slows Myopia Progression in Hong Kong Chinese Schoolchildren : A 2-Year Randomised Clinical Trial . Br J Ophthalmol 2014 ; 98 : 40 – 45 .
10 . Ruiz-Pomeda A , Perez-Sanchez B , Valls I [ et al .]. Misight Assessment Study Spain ( Mass ). A 2-Year Randomized Clinical Trial . Graefe ’ s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2018 ; 256 : 1011 – 1021 .
11 . Sankaridurg P , Bakaraju RC , Naduvilath T [ et al .]. Myopia Control with Novel Central and Peripheral Plus Contact Lenses and Extended Depth of Focus Contact Lenses : 2 Year Results from a Randomised Clinical Trial . Ophthalmic Physiol Opt 2019 ; 39 : 294 – 307 .
12 . Charm J , Cho P . High Myopia-Partial Reduction Ortho-K : A 2-Year Randomized Study . Optom Vis Sci 2013 ; 90 : 530 – 539 .
13 . Cho P , Cheung SW . Retardation of Myopia in Orthokeratology ( Romio ) Study : A 2-Year Randomized Clinical Trial . Invest Ophthalmol Vis Sci 2012 ; 53 : 7077 – 7085 .
14 . Lam CSY , Tang WC , Tse DY [ et al .]. Defocus Incorporated Multiple Segments ( Dims ) Spectacle Lenses
Slow Myopia Progression : A 2-Year Randomised Clinical Trial . Br J Ophthalmol 2019 .
15 . Bao J , Yang A , Huang Y [ et al .]. One-Year Myopia Control Efficacy of Spectacle Lenses with Aspherical Lenslets . Br J Ophthalmol 2021 .
16 . Cho P , Cheung SW , Edwards M . The Longitudinal Orthokeratology Research in Children ( Loric ) in Hong Kong : A Pilot Study on Refractive Changes and Myopic Control . Curr Eye Res 2005 ; 30 : 71 – 80 .
17 . Bullimore MA , Brennan NA . Myopia Control : Why Each Diopter Matters . Optom Vis Sci 2019 ; 96 : 463 – 465 .
18 . Cheung SW , Cho P . Validity of Axial Length Measurements for Monitoring Myopic Progression in Orthokeratology . Invest Ophthalmol Vis Sci 2013 ; 54 : 1613 – 1615 .
19 . Chia A , Chua WH , Cheung YB [ et al .]. Atropine for the Treatment of Childhood Myopia : Safety and Efficacy of 0.5 %, 0.1 %, and 0.01 % Doses ( Atropine for the Treatment of Myopia 2 ). Ophthalmology 2012 ; 119 : 347 – 354 .
20 . Yam JC , Li FF , Zhang X [ et al .]. Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression ( Lamp ) Study : Phase 2 Report . Ophthalmology 2020 ; 127 : 910 – 919 .
21 . Fulk GW , Cyert LA , Parker DA . Seasonal Variation in Myopia Progression and Ocular Elongation . Optom Vis Sci 2002 ; 79 : 46 – 51 .
22 . Gwiazda J , Deng L , Manny R [ et al .]. Seasonal Variations in the Progression of Myopia in Children Enrolled in the Correction of Myopia Evaluation Trial . Invest Ophthalmol Vis Sci 2014 ; 55 : 752 – 758 .
23 . Zadnik K , Mutti DO , Mitchell GL [ et al .]. Normal Eye Growth in Emmetropic Schoolchildren . Optom Vis Sci 2004 ; 81 : 819 – 828 .
24 . Kinoshita N , Konno Y , Hamada N [ et al .]. Efficacy of Combined Orthokeratology and 0.01 % Atropine Solution for Slowing Axial Elongation in Children with Myopia : A 2-Year Randomised Trial . Sci Rep 2020 ; 10 : 12750 .
25 . Kinoshita N , Konno Y , Hamada N [ et al .]. Additive Effects of Orthokeratology and Atropine 0.01 % Ophthalmic Solution in Slowing Axial Elongation in Children with Myopia : First Year Results . Japanese journal of ophthalmology 2018 ; 62 : 544 – 553 .
26 . Chen Z , Huang S , Zhou J [ et al .]. Adjunctive Effect of Orthokeratology and Low Dose Atropine on Axial Elongation in Fast-Progressing Myopic Children – a Preliminary Retrospective Study . Cont Lens Anterior Eye 2019 ; 42 : 439 – 42 .
27 . Tan Q , Ng AL , Choy BN [ et al .]. One-Year Results of 0,01 % Atropine with Orthokeratology ( Aok ) Study : A Randomised Clinical Trial . Ophthalmic Physiol Opt 2020 ; 40 : 557 – 566 .
28 . Huang J , Mutti DO , Jones-Jordan LA , Walline JJ . Bifocal & Atropine in Myopia Study : Baseline Data and Methods . Optom Vis Sci 2019 ; 96 : 335 – 344 .
Should we control myopia progression or eye growth ?
The article discusses the reasons for and against the measurement of the axial length of the eye in the control of myopia in children . Recommendations are given on the interpretation of measurement data and the correction of treatment methods .
Keywords : eye growth , myopia control , optical biometr , orthokeratology
Äæåôôðè Äæ . Óîëëèí ( Jeffrey J . Walline ), äîêòîð ôèëîñîôèè , îïòîìåòðèñò , çàìåñòèòåëü äåêàíà êàôåäðû èññëåäîâàíèé â êîëëåäæå îïòîìåòðèè Ãîñóäàðñòâåííîãî óíèâåðñèòåòà Îãàéî ( Êîëóìáóñ , ÑØÀ )
38
ÑÎÂÐÅÌÅÍÍÀß ÎÏÒÎÌÅÒÐÈß ¹ 10 ( äåêàáðü ) 2021